Product
Solutions
Developers
Resources
Pricing
Security
Book a demo
Product
IP WORK
Patent Search & Analysis
Novelty Search
FTO Search
Design FTO Search
Patent Drafting & OAR
SEP Assessment
R&D WORK
Tech Research & Engineering
Find Solutions with TRIZ
Drug Discovery & Research
SAR Data Extraction
Materials R&D
Formulation
Solutions
BY USE CASE
Competitor Tech Research
Design Risk Screening
Cosmetic Formulation
Telecom SEP Claim Chart
Explore free tools for quick IP tasks
View all tools
Developers
MCP Servers
APIs
Skill Hub
UI Widgets
Resources
LEARN
How to eureka
NEW
PatentBench
DISCOVER
Blog & Insights
Customer Stories
Free AI Tools
Support
Help Center
Pricing
Security
Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.
1
results about How to "Reduced burst effect" patented technology
Filter
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A vitamin A-functionalized polyphenol-phospholipid complex, its preparation method and application
Pending
CN122297705A
Good dispersion
Improve in vivo stability
Liver fibrosis
Phospholipid complex
This invention discloses a
vitamin
A-functionalized
polyphenol
-
phospholipid
complex, its preparation method, and its applications, belonging to the field of
pharmaceutical formulation
and nanodelivery technology. The
phospholipid
complex comprises a
polyphenol
drug
, a
phospholipid
material, and a
vitamin
A phospholipid ligand. The
vitamin
A phospholipid ligand is formed by vitamin A or its derivatives and a phospholipid derivative containing amino or other reactive groups. The
phospholipid complex
forms a phospholipid
composite structure
through non-covalent interactions between the
polyphenol
drug
and the phospholipid material, and the vitamin A phospholipid ligand is inserted into or assembled into the surface or interior of the phospholipid
composite structure
. Animal experiments show that this
phospholipid complex
can reduce
serum transaminase
levels and alleviate the degree of
liver fibrosis
, and has good
blood compatibility
and tissue safety. This invention provides an industrially achievable targeted nano-formulation solution for early intervention in
liver fibrosis
, with promising application prospects.
View all
Owner:
SHENYANG PHARMA UNIV
Login to View More